-
Cunningham to miss another week for NBA Pistons
-
Lyon beat Wolfsburg to reach Women's Champions League semis
-
Mickelson withdraws from Masters over family matter
-
NASA gives Artemis crew green light to head towards Moon
-
Blues rugby player retires after terminal cancer diagnosis
-
Trump ballroom approved by panel, remains stalled by judge
-
Resilient Pegula reaches WTA Charleston quarters with tiebreak win
-
Pakistan hikes petrol, diesel prices due to Middle East war
-
Trump orders new pharma tariff, reshapes metal duties
-
Music and barbecues in Tehran despite Trump threats
-
Bielle-Biarrey voted best player of Six Nations for second time
-
Veteran QB Cousins to join Raiders: reports
-
El Ghazi records final legal victory over Israel-Hamas posts
-
Barca crush Real Madrid to reach women's Champions League semis
-
UK police set up national hub to cut illegal knife sales
-
French mayor denounces 'increasingly racist society'
-
Trump sacks attorney general, replaces with ex-personal lawyer
-
Head, Abhishek help Hyderabad thump Kolkata in IPL
-
Trump sacks Bondi, appoints ex-personal attorney to head justice dept
-
PSG return to domestic action with focus on Liverpool
-
Cubans demand end of US embargo in bike protest
-
Body camera video released from Woods arrest
-
Artemis astronauts await green light for lunar orbit
-
Travolta returns to Cannes with aviation-inspired directorial debut
-
Grain, steel, fertiliser blocked by Hormuz closure: data
-
De Zerbi to stay at Tottenham next season 'no matter what'
-
Four children stabbed to death at Ugandan nursery: police
-
Trump urges Bruce Springsteen boycott in social media rant
-
US banks in Paris tighten security, order remote work over pro-Iran threat
-
Israeli politicians, ex-security officials slam 'Jewish terrorism' in West Bank
-
Bashir retains England 'ambition' despite Ashes snub
-
US trade deficit widens less than forecast as tariff turmoil persists
-
UEFA chief Ceferin warns Italy could lose Euro 2032 without stadium improvements
-
Oil rallies, stocks drop as Trump dashes hopes fighting will soon end
-
Italy's football chief resigns after World Cup disaster
-
Edoardo Molinari named European vice-captain for Ryder Cup
-
'Extraordinary news': Dutch recover stolen gold Romanian helmet
-
France considers reform for New Caledonia
-
UK foreign minister stresses 'urgent need' to reopen Hormuz strait
-
Macron says Trump marriage jibe does not 'merit response'
-
Russia will send second ship with oil to Cuba: minister
-
Belgian bishop takes on Vatican with push to ordain married men
-
Nexperia's China unit nears fully local production of chips: company sources
-
Indonesia issues fresh summons for Google, Meta over teen social media ban
-
India's says defence exports hit 'all-time high' of $4 bn
-
Nielsen leaves as Japan coach weeks after winning Women's Asian Cup
-
Too bright: Seoul to dim digital billboards after complaints
-
Iran vows 'crushing' attacks on US after Trump threats
-
Women's Asian Cup finalists accuse governing body over equal money
-
French president Macron heads to South Korea after Japan visit
Trump orders new pharma tariff, reshapes metal duties
US President Donald Trump on Thursday ordered new tariffs on certain medicines, alongside an overhaul of metal duties, doubling down on his trade agenda a year after unleashing trade wars on virtually all partners.
The latest pair of orders he signed pile pressure on pharmaceutical companies to manufacture more in the United States, while separately targeting firms that officials accuse of "artificially manipulating" metals prices.
Finished products containing substantial amounts of steel, aluminum and copper will also face a 25-percent tariff on their full value instead of being targeted for the amount of metals they contain -- a shift that could fan worries about higher consumer prices.
The moves come on the anniversary of what Trump had dubbed "Liberation Day," when he announced varying tariff rates on goods from dozens of economies, roiling financial markets and snarling supply chains.
Although the Supreme Court struck down these global tariffs this February, Trump has been working to reinstate duties using different authorities.
His stated aim of "Liberation Day" was the rebirth of American industry, bringing an influx of jobs, revenue and an investment boom -- although critics argue that these have largely not taken place.
Making good on his threat last fall, one of Trump's Thursday orders imposes a 100-percent tariff on patented pharmaceuticals made abroad unless countries struck trade deals to secure lower rates, or companies commit to building plants in the United States.
Large companies will have 120 days to commit to "reshoring plans" before the steep duty kicks in, while smaller companies have a 180-day buffer, a senior US official told reporters.
"We expect the lion's share of the world's patented pharmaceuticals to be building in America," the official said.
Those who commit to building manufacturing plants -- to be completed by the end of Trump's second presidency -- will face a 20-percent tariff instead.
The European Union, Japan, South Korea and Switzerland will be excluded from this plan and face a 15-percent pharma duty, due to trade deals they earlier struck with Washington.
Meanwhile, drug companies that reach "Most Favored Nation" pricing deals with the Trump administration, while also building plants in the United States, can be exempt from the sharp pharma tariff.
- Affordability hit? -
The second order Trump signed reshapes his 50-percent tariffs on steel, aluminum and copper, pushing importers to pay the duty based on prices that American buyers are facing.
It is set to take effect 12.01am Eastern Time on Monday, a White House official told AFP.
The senior administration official charged that "foreign countries were artificially manipulating" prices of imported metals in order to pay a lower tariff.
The same proclamation called for finished products made with more than 15 percent of steel, aluminum and copper will face a 25-percent tariff on their full value, rather than being targeted based on their metal content.
"It's a simplification and a fairness issue," the official said.
Asked about cost of living concerns, which have flared ahead of midterm elections this year, the official maintained: "I don't think it's going to have any impact in affordability."
"These will not have impact on the price of the good on the shelf," the official insisted.
T.Suter--VB